tiprankstipranks
Advertisement
Advertisement

JP:4583 Stock Latest News

Chiome Bioscience Outlines Q1 FY2026 Results and Pipeline Focus
Company AnnouncementsChiome Bioscience Outlines Q1 FY2026 Results and Pipeline Focus
7d ago
4583
Chiome Bioscience Narrows Quarterly Loss as Equity Ratio Improves, Keeps Cautious Outlook
PremiumCompany Announcements
Chiome Bioscience Narrows Quarterly Loss as Equity Ratio Improves, Keeps Cautious Outlook
7d ago
4583
Chiome Bioscience Corrects FY2025 Results as Losses and Cash Burn Persist
PremiumCompany Announcements
Chiome Bioscience Corrects FY2025 Results as Losses and Cash Burn Persist
2M ago
4583
Chiome Bioscience Outlines FY2025 Results and mAb Development Focus
PremiumCompany Announcements
Chiome Bioscience Outlines FY2025 Results and mAb Development Focus
3M ago
4583
Chiome Bioscience Widens Cash Burn as Sales Drop and Outlook Stays Limited
PremiumCompany Announcements
Chiome Bioscience Widens Cash Burn as Sales Drop and Outlook Stays Limited
3M ago
4583
Chiome Bioscience Reports Continued Losses Amidst Declining Sales
PremiumCompany AnnouncementsChiome Bioscience Reports Continued Losses Amidst Declining Sales
6M ago
4583
Chiome Bioscience’s CBA-1205: A Promising Phase I Study Update
Premium
Company Announcements
Chiome Bioscience’s CBA-1205: A Promising Phase I Study Update
7M ago
4583
Chiome Bioscience’s Innovative Phase I Study on CBA-1535: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Chiome Bioscience’s Innovative Phase I Study on CBA-1535: A Potential Game-Changer in Cancer Treatment
7M ago
4583
Chiome Bioscience Reports First Half 2025 Financial Results
PremiumCompany Announcements
Chiome Bioscience Reports First Half 2025 Financial Results
9M ago
4583
Chiome Bioscience Reports Q1 2025 Financial Results Amid Continued Losses
PremiumCompany Announcements
Chiome Bioscience Reports Q1 2025 Financial Results Amid Continued Losses
1y ago
4583
Chiome Bioscience Updates Financial Results for FY 2024
PremiumCompany Announcements
Chiome Bioscience Updates Financial Results for FY 2024
1y ago
4583
Chiome Bioscience and OmniAb Collaborate on Antibody Research
PremiumCompany Announcements
Chiome Bioscience and OmniAb Collaborate on Antibody Research
1y ago
4583
Chiome Bioscience Reports Modest Sales Growth Amid Continued Financial Challenges
PremiumCompany AnnouncementsChiome Bioscience Reports Modest Sales Growth Amid Continued Financial Challenges
1y ago
4583
Chiome Bioscience’s Tribody™ Technology Shows Promising Results in Cancer Immunotherapy
Premium
Company Announcements
Chiome Bioscience’s Tribody™ Technology Shows Promising Results in Cancer Immunotherapy
1y ago
4583
Chiome Bioscience’s Promising Results in CBA-1205 Phase I Study
Premium
Company Announcements
Chiome Bioscience’s Promising Results in CBA-1205 Phase I Study
1y ago
4583
Chiome Bioscience Unveils Promising Cancer Therapy Data
PremiumCompany Announcements
Chiome Bioscience Unveils Promising Cancer Therapy Data
1y ago
4583
Chiome Bioscience Secures Licensing Deal with Asahi Kasei
PremiumCompany Announcements
Chiome Bioscience Secures Licensing Deal with Asahi Kasei
1y ago
4583
Chiome Bioscience Secures Key Licensing Deal
PremiumCompany Announcements
Chiome Bioscience Secures Key Licensing Deal
2y ago
4583
Chiome Bioscience Revises Forecast Amid Financial Challenges
PremiumCompany Announcements
Chiome Bioscience Revises Forecast Amid Financial Challenges
2y ago
4583
Chiome Bioscience Reports Decreased Half-Year Results
PremiumCompany AnnouncementsChiome Bioscience Reports Decreased Half-Year Results
2y ago
4583
Chiome Bioscience Begins Phase I Trial for Cancer Drug
Premium
Company Announcements
Chiome Bioscience Begins Phase I Trial for Cancer Drug
2y ago
4583

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >